Exane Derivatives’s Kemper KMPR Stock Holding History

Exane Derivatives’s Portfolio KMPR Stock Details KMPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-572	Closed	-$45.6K	–	1065
2021 Q1	$45.6K	Buy	+572	New	+$44.1K	0.01%	527

Other funds holding KMPR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Natural Investments Windsor, California $455M AUM 27.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Exane Derivatives's KMPR Position: Q2 2021 in Review

Exane Derivatives sold out of Kemper (KMPR) in Q2 2021, closing a stake of 572 shares — an estimated $45.6K sold.

Exane Derivatives first reported a position in KMPR in Q1 2021 and held it in 1 quarter. The position peaked at $45.6K in Q1 2021. 251 funds tracked by Wall St. Rank hold KMPR as of Q2 2021.

Exane Derivatives reported no remaining Kemper position as of Q2 2021 after selling out during the quarter.
Exane Derivatives sold 572 Kemper shares in Q2 2021, an estimated $45.6K.
Exane Derivatives first reported a position in Kemper in Q1 2021 and held it in 1 quarter.
Exane Derivatives's Kemper position peaked at $45.6K in Q1 2021.
251 funds tracked by Wall St. Rank held Kemper as of Q2 2021.

Based on Exane Derivatives's 13F filing for Q2 2021, filed 28 Jul 2021.